These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 8222459

  • 1. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA, Stoeckel K.
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review.
    Stoeckel K, Tam YK, Kneer J.
    Curr Med Res Opin; 1989 Sep; 11(7):432-41. PubMed ID: 2673663
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.
    Blouin RA, Kneer J, Stoeckel K.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):291-6. PubMed ID: 2729925
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
    Koup JR, Dubach UC, Brandt R, Wyss R, Stoeckel K.
    Antimicrob Agents Chemother; 1988 Apr; 32(4):573-9. PubMed ID: 3377466
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
    Hayton WL, Kneer J, Blouin RA, Stoeckel K.
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
    [Abstract] [Full Text] [Related]

  • 6. Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Bryson HM, Brogden RN.
    Drugs; 1993 Apr; 45(4):589-621. PubMed ID: 7684677
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children.
    Hayton WL, Walstad RA, Thurmann-Nielsen E, Kufaas T, Kneer J, Ambros RJ, Rugstad HE, Monn E, Bodd E, Stoeckel K.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):720-5. PubMed ID: 2069377
    [Abstract] [Full Text] [Related]

  • 8. Bioavailability of syrup and tablet formulations of cefetamet pivoxil.
    Ducharme MP, Edwards DJ, McNamara PJ, Stoeckel K.
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2706-9. PubMed ID: 8109939
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency.
    Kneer J, Tam YK, Blouin RA, Frey FJ, Keller E, Stathakis C, Luginbuehl B, Stoeckel K.
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1952-7. PubMed ID: 2610506
    [Abstract] [Full Text] [Related]

  • 10. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.
    Blouin RA, Kneer J, Ambros RJ, Stoeckel K.
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1744-8. PubMed ID: 1981000
    [Abstract] [Full Text] [Related]

  • 11. Cefetamet pivoxil: comparable evaluation with other orally available antibiotics against selected species of respiratory pathogens.
    Speciale A, Caccamo F, Blandino G, Giacchi GT, Aleo G, Nicoletti G.
    Chemotherapy; 1996 Sep; 42(1):1-10. PubMed ID: 8751262
    [Abstract] [Full Text] [Related]

  • 12. Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxil.
    Holford NH, Ambros RJ, Stoeckel K.
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):421-42. PubMed ID: 1287195
    [Abstract] [Full Text] [Related]

  • 13. Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy.
    Cullmann W, Edwards DJ, Kissling M, Kneer J, Stoeckel K, Urwyler H.
    Int J Antimicrob Agents; 1992 Oct; 1(4):175-91. PubMed ID: 18611503
    [Abstract] [Full Text] [Related]

  • 14. Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers.
    Tam YK, Kneer J, Dubach UC, Stoeckel K.
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1556-9. PubMed ID: 2221865
    [Abstract] [Full Text] [Related]

  • 15. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
    Angehrn P, Hohl P, Then RL.
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers.
    Tam YK, Kneer J, Dubach UC, Stoeckel K.
    Antimicrob Agents Chemother; 1989 Jun; 33(6):957-9. PubMed ID: 2764545
    [Abstract] [Full Text] [Related]

  • 17. Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants.
    Hayton WL, Kneer J, de Groot R, Stoeckel K.
    Antimicrob Agents Chemother; 1996 Mar; 40(3):567-74. PubMed ID: 8851572
    [Abstract] [Full Text] [Related]

  • 18. Literature survey on clinical efficacy and tolerability on cefetamet pivoxil: an analysis of 3,128 cases.
    Kissling M, Chadbourne U.
    Respiration; 1993 Mar; 60 Suppl 1():45-54. PubMed ID: 8480090
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
    Kees F, Naber KG.
    Infection; 1990 Mar; 18 Suppl 3():S150-4. PubMed ID: 2079377
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cefetamet in plasma and skin blister fluid.
    Zimmerli W, Sansano S, Wittke B.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):102-4. PubMed ID: 8787888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.